I am neither a heart scientist nor a rocket surgeon, but noting the comment by the author, Dr Cavalcante, at the end of this summation:
"Cardiac MRI also detected asignificant left ventricular mass index regression at 6 months post-TAVR"
Expanded left ventricular mass - LVM - is not a good thing, and thus regression is a positive.
For example, to quote a report regarding heart treatment more generally ( in connection with CKD - chronic kidney disease ):
LVM regression may be a useful surrogate marker for benefits of interventions intended to reduce mortality risk in patients with CKD
From https://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-022-02666-1
- Forums
- ASX - By Stock
- Ann: Data Update on First-in-Human Study of DurAVR at NY Valves
I am neither a heart scientist nor a rocket surgeon, but noting...
-
- There are more pages in this discussion • 44 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$18.31 |
Change
-0.240(1.29%) |
Mkt cap ! $351.9M |
Open | High | Low | Value | Volume |
$18.80 | $19.15 | $18.20 | $159.7K | 8.611K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 73 | $18.31 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.33 | 90 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 150 | 18.100 |
1 | 100 | 18.050 |
1 | 250 | 18.010 |
2 | 2010 | 18.000 |
1 | 55 | 17.910 |
Price($) | Vol. | No. |
---|---|---|
19.000 | 500 | 1 |
20.000 | 2950 | 4 |
20.120 | 420 | 1 |
20.200 | 309 | 1 |
20.400 | 678 | 1 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online